Acadian Asset Management’s Relmada Therapeutics RLMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $371K | Sell |
619,479
-608,449
| -50% | -$364K | ﹤0.01% | 1198 |
|
|
2025
Q1 | $329K | Hold |
1,227,928
| – | – | ﹤0.01% | 1162 |
|
|
2024
Q4 | $636K | Buy |
1,227,928
+41,476
| +3% | +$21.5K | ﹤0.01% | 1021 |
|
|
2024
Q3 | $3.84M | Sell |
1,186,452
-6,881
| -0.6% | -$22.3K | 0.01% | 567 |
|
|
2024
Q2 | $3.58M | Buy |
1,193,333
+12,147
| +1% | +$36.4K | 0.01% | 590 |
|
|
2024
Q1 | $5.49M | Sell |
1,181,186
-1,639
| -0.1% | -$7.62K | 0.02% | 447 |
|
|
2023
Q4 | $4.89M | Buy |
1,182,825
+10,102
| +0.9% | +$41.8K | 0.02% | 463 |
|
|
2023
Q3 | $3.51M | Sell |
1,172,723
-48,676
| -4% | -$146K | 0.01% | 541 |
|
|
2023
Q2 | $3M | Hold |
1,221,399
| – | – | 0.01% | 587 |
|
|
2023
Q1 | $2.76M | Buy |
1,221,399
+121,060
| +11% | +$273K | 0.01% | 625 |
|
|
2022
Q4 | $3.83M | Buy |
+1,100,339
| New | +$3.83M | 0.02% | 520 |
|